ES2040774T3 - Procedimiento para la preparacion de una formulacion medicamentosa. - Google Patents

Procedimiento para la preparacion de una formulacion medicamentosa.

Info

Publication number
ES2040774T3
ES2040774T3 ES198888106348T ES88106348T ES2040774T3 ES 2040774 T3 ES2040774 T3 ES 2040774T3 ES 198888106348 T ES198888106348 T ES 198888106348T ES 88106348 T ES88106348 T ES 88106348T ES 2040774 T3 ES2040774 T3 ES 2040774T3
Authority
ES
Spain
Prior art keywords
procedure
preparation
drug formulation
active
coronary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888106348T
Other languages
English (en)
Inventor
Jurgen Block
Lutz Feicho
Alwin Sobe
Martin Wischniewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Kali Chemie Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma GmbH filed Critical Kali Chemie Pharma GmbH
Application granted granted Critical
Publication of ES2040774T3 publication Critical patent/ES2040774T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCRIBEN FORMULACIONES DE MEDICAMENTOS QUE CONTIENEN, JUNTO A UN PRINCIPIO ACTIVO SOBRE LAS CORONARIAS PERTENECIENTE AL GRUPO DE LOS NITRATOS DE ISOSORBIDA O DIHIDROPIRIDINAS, UN ETER ALQUILENGLICOLICO COMO DISOLVENTE.
ES198888106348T 1987-04-30 1988-04-21 Procedimiento para la preparacion de una formulacion medicamentosa. Expired - Lifetime ES2040774T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873714402 DE3714402A1 (de) 1987-04-30 1987-04-30 Arzneimittelformulierung

Publications (1)

Publication Number Publication Date
ES2040774T3 true ES2040774T3 (es) 1993-11-01

Family

ID=6326574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888106348T Expired - Lifetime ES2040774T3 (es) 1987-04-30 1988-04-21 Procedimiento para la preparacion de una formulacion medicamentosa.

Country Status (9)

Country Link
US (1) US4976965A (es)
EP (1) EP0288895B1 (es)
JP (1) JPS63280024A (es)
AT (1) ATE65400T1 (es)
DE (2) DE3714402A1 (es)
ES (1) ES2040774T3 (es)
GR (1) GR3002420T3 (es)
HU (1) HU201872B (es)
PT (1) PT86887B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237638B (it) * 1989-10-25 1993-06-12 Ghirardi Paolo E. Impiego dell'isosorbide 2-mononitrato per la preparazione di composi- zioni farmaceutiche atte al trattamento dell'angina pectoris
DE4007705C1 (es) * 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
GB2285921A (en) * 1994-01-31 1995-08-02 Leilani Lea Sublingual administration of medicaments
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
US20050152972A1 (en) * 2004-01-14 2005-07-14 Mohinder Singh Soft chewable anesthetic lozenges
EP2254898B1 (en) 2008-03-24 2015-07-15 Archer Daniels Midland Co. Method for preparation of anhydrosugar ethers

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (es) * 1962-05-24
DE1792448C3 (de) * 1967-09-11 1974-10-03 Richter Gedeon Vegyeszeti Gyar R.T., Budapest Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten
US3579392A (en) * 1967-11-27 1971-05-18 Nitro Nobel Ab Nitroglycerin-nitroglycol blasting composition
SE401818B (sv) * 1967-11-27 1978-05-29 Nitro Nobel Ab Forfarande med forhojd sekerhet vid framstellning av ett extruderbart, hanteringssekert och med en sprengkapsel initerbart sprengemne
SU432703A3 (es) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
GB2095107A (en) * 1981-03-24 1982-09-29 Janssen Pharmaceutica Nv Tetramisole-or levamisole pour-on compositions
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
DE3315805A1 (de) * 1983-04-30 1984-11-08 Bayer Ag, 5090 Leverkusen Wirkstoffzubereitungen
ATE33348T1 (de) * 1983-11-30 1988-04-15 Siegfried Ag Coronartherapeutikum in form von weichgelatinekapseln.
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3570598D1 (en) * 1984-11-15 1989-07-06 Nitto Denko Corp Composition for percutaneous administration
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
CH668553A5 (de) * 1987-02-02 1989-01-13 Mepha Ag Arzneimittel mit verzoegerter wirkstofffreisetzung.

Also Published As

Publication number Publication date
HUT46846A (en) 1988-12-28
EP0288895A1 (de) 1988-11-02
PT86887A (pt) 1988-04-01
HU201872B (en) 1991-01-28
PT86887B (pt) 1992-07-31
DE3863830D1 (de) 1991-08-29
EP0288895B1 (de) 1991-07-24
ATE65400T1 (de) 1991-08-15
DE3714402A1 (de) 1988-11-10
JPS63280024A (ja) 1988-11-17
US4976965A (en) 1990-12-11
GR3002420T3 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
SE8602723L (sv) Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem
PT91246A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
FI92014C (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
SE8700499D0 (sv) Novel pharmacologically active compounds
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
SE9000441D0 (sv) Novel cyclosporin galenic forms
FI842294A0 (fi) Nya galeniska preparatformer foer orala antidiabetmedel och foerfarande foer deras framstaellning.
ES2052745T3 (es) Formulaciones farmaceuticas que contienen melfalan o hidrocloruro de melfalan, asi como melfalan e hidrocloruro de melfalan y procedimientos para prepararlas.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES525574A0 (es) Procedimiento para producir preparaciones farmaceuticas que contienen como substancias activas derivados de polialquilenglicol.
ES2040774T3 (es) Procedimiento para la preparacion de una formulacion medicamentosa.
BG60101A3 (en) Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
GB2021409A (en) Pharmaceutical composition
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
IL82925A0 (en) Tetrahydrobenzothiazoles,their preparation and pharmaceutical compositions containing them
SE8503447L (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
GT199000039A (es) Compuestos heterociclicos.
ATE155041T1 (de) Rectale pharmazeutische zubereitung fuer die behandlung von prostataanschwellung
GB1290291A (es)
IT8019068A0 (it) Composizione farmaceutica per la somministrazione topica di nifedipina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 288895

Country of ref document: ES